Company / Capital Expenditures
Enovis Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$197.4M
FY2025
5-year range
$104.2M / $197.4M
FY2021-FY2025
Trend
+9.2%
vs FY2024
Sector context
#43 of 151
Health Care
What the data says
At $197M, Enovis's capital expenditures ranks #43 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $63M in FY2016 to $197M in FY2025.
Based on SEC 10-K filings.
$197M in FY2025 with a 5-year CAGR of +23.2%.
Improved from $104M to $197M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +19.8%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Sector benchmark
#43 of 151 in Health CareTop 28% of 151This company $197.4M Sector average $271.7M
▼
-27.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +23.2%, indicating consistent growth.
- In FY2025, capital expenditures increased 9.2% year-over-year.
- Ranks #43 out of 151 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $197.4M | +9.2% |
| FY2024 | $180.7M | +73.4% |
| FY2023 | $104.2M | -9.2% |
| FY2022 | $114.8M | +10.1% |
| FY2021 | $104.2M | +49.7% |
| FY2020 | $69.6M | +1.3% |
| FY2019 | $68.8M | -1.3% |
| FY2018 | $69.6M | -0.3% |
| FY2017 | $69.9M | +10.5% |
| FY2016 | $63.3M | -11.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026